The earnings call revealed a mixed performance for BIO-key. While there are positive developments such as revenue growth compared to the previous quarter, a high gross profit margin, and strategic expansions in various regions and sectors, the company faced challenges with a year-over-year revenue decline and increased net loss. The transition strategy in EMEA and improvements in the balance sheet are promising, but the overall financial performance had some setbacks.
Company Guidance
During BIO-key International's Q1 2025 conference call, the company reported a 10% increase in revenue to $1.6 million compared to Q4 2024, despite a $1.2 million revenue impact from the previous year's contract. A key customer upgraded to a more advanced biometric solution, accounting for $690,000 of Q1 revenue, with expectations for future revenue to double to $3 million over a two-year period starting Q1 2026. Gross profit remained healthy at 83%, aided by a high-margin Software-as-a-Service model, while SG&A expenses were reduced by 23% year-over-year. The company's cash position increased significantly to over $3 million due to warrant exercises, and the note payable was reduced to approximately $762,000 from an original $2.3 million. BIO-key sees growth opportunities in the EMEA region and government sectors, with significant traction in defense and financial services verticals. They are also expanding their base in the education sector, driven by compliance with phone-free school regulations in California. Overall, BIO-key is focused on sequential growth and improving top and bottom-line results, supported by a growing base of recurring revenue, which currently stands at over $6 million.
Revenue Growth in Q1 2025
BIO-key's Q1 '25 revenue rose 10% to $1.6 million versus Q4 '24, driven by a focus on selling high-margin BIO-key branded products in EMEA.
High Gross Profit Margin
The company maintained a healthy gross profit margin of 83% in Q1 '25 due to its high-margin Software-as-a-Service model.
Improved Cash Position
BIO-key's cash position increased to over $3 million, reflecting proceeds from warrant exercises early in the quarter.
Expansion in EMEA Region
Improving traction and particular interest in BIO-key's differentiated identity-bound biometrics capabilities in the EMEA region.
Strategic Partnership in Education Sector
Executed a strategic partnership with California's EdTech Joint Powers Authority, making PortalGuard an approved solution for 195 K-12 schools and districts.
BIO-key International (BKYI) Earnings, Revenues Date & History
The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
BKYI Earnings-Related Price Changes
Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
May 15, 2025
$0.85
$0.83
-2.35%
Mar 27, 2025
$1.12
$0.86
-23.21%
Nov 14, 2024
$1.02
$0.94
-7.84%
Aug 14, 2024
$1.40
$1.25
-10.71%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does BIO-key International Inc (BKYI) report earnings?
BIO-key International Inc (BKYI) is schdueled to report earning on Aug 18, 2025, TBA Not Confirmed.
What is BIO-key International Inc (BKYI) earnings time?
BIO-key International Inc (BKYI) earnings time is at Aug 18, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.